CORPORATE SYMPOSIA

Monday 16 September 2019

Transforming Transplantation: From Current Practice to Future Options – Organised by Novartis

Monday 16 September 2019 – 13:00 to 14:00 – Room A2

Moderator: Franco Citterio

  • Latest data from current IS therapies to cover unmet medical needs in Renal Transplantation
    Nassim Kamar (France)
  • Future treatment options
    Helio Tedesco (Brazil)

Adapting our approach to patients’ need: can sensitivity to tacrolimus PK become a potential driver in clinical practice? – Organised by Chiesi

Monday 16 September 2019 – 13:00 to 14:00 – Room A15

Chair: R. Oberbauer (Austria) 

  • Early identification of tacrolimus PK sensitivity in kidney transplanted patients
    L. Furian (Italy)
  • Exploring new aspects of clinical PK sensitivity: management of liver transplanted patients
    F. Saliba (France)

Tuesday 17 September 2019

Management of highly sensitised kidney transplant candidates:current and future approaches – Organised by Hansa Biopharma

Tuesday 17 September 2019 – 17:00 to 18:30 – Room c1m1
This event is for healthcare professionals only

Chairs: Alexandre Loupy, Necker Hospital, Paris, France & Torbjörn Lundgren, Karolinska University Hospital, Stockholm, Sweden

  • Improving access for the highly sensitised candidate: current opportunities and on-going challenges
    Oriol Bestard, Bellvitge University Hospital, Barcelona, Spain
  • Transplanting the highly sensitised candidate: current approaches to desensitisation
    Carmen Lefaucheur, Saint-Louis Hospital-APHP, Paris, France
  • Mitigating antibody-mediated rejection in the highly sensitised candidate: identification & treatment
    Farsad Eskandary, Medical University of Vienna, Austria
  • Novel approaches and future goals for transplanting the highly sensitised candidate
    Nizam Mamode, Guy’s and St Thomas’ NHS Foundation Trust, London, UK